FDA approves Genentech's fast-acting single-dose flu medicine Xofluza

FDA approves Genentech's fast-acting single-dose flu medicine Xofluza: Baloxavir, the only single-dose, oral medicine approved to treat the flu, has been shown to dramatically reduce the duration of symptoms.